PRESS RELEASE published on 02/06/2025 at 07:30, 1 year ago Réalisation des opérations annoncées en décembre 2024 relatives a la modification des obligations convertibles souscrites par une entité affiliée à Heights Capital Management, Inc. (« Heights ») et l’émission d’une seconde tranche ass Crossject annonce la réalisation des opérations relatives à la modification des obligations convertibles souscrites par une entité affiliée à Heights Capital Management et l'émission d'une seconde tranche assimilable Obligations Convertibles Émission Crossject Heights Capital Management Tranche Assimilable
PRESS RELEASE published on 02/06/2025 at 07:30, 1 year ago COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE Crossject completes transactions announced in December 2024 related to amendment of convertible bonds subscribed by an entity affiliated to Heights Capital Management, Inc. Second assimilable tranche issued Convertible Bonds Transaction Bond Issue Crossject Heights Capital Management
BRIEF published on 01/20/2025 at 14:47, 1 year 1 month ago Crossject : Mise à jour sur les droits de vote et actions au 31 décembre 2024 Droits De Vote Capital Social Actions 2024 Crossject
BRIEF published on 01/20/2025 at 14:47, 1 year 1 month ago Crossject: Update on voting rights and shares as of December 31, 2024 Share Capital Voting Rights Actions 2024 Crossject
PRESS RELEASE published on 01/20/2025 at 14:42, 1 year 1 month ago Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Crossject publie le nombre total de droits de vote et d'actions au 31 décembre 2024. La société développe des médicaments d'urgence Droits De Vote Actions AMF Crossject Médicaments D'urgence
BRIEF published on 12/31/2024 at 10:02, 1 year 1 month ago Crossject : Détails sur le Capital Social et les Droits de Vote au 30 Novembre 2024 Droits De Vote Capital Social Actions AMF Crossject
BRIEF published on 12/31/2024 at 10:02, 1 year 1 month ago Crossject: Details on Share Capital and Voting Rights as of November 30, 2024 Share Capital Voting Rights Actions AMF Crossject
PRESS RELEASE published on 12/31/2024 at 09:57, 1 year 1 month ago Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Crossject publie le nombre total de droits de vote et d'actions au 30 novembre 2024 conformément aux réglementations. Prochainement, il commercialisera des médicaments d'urgence Droits De Vote Actions AMF Crossject Médicaments D'urgence
BRIEF published on 12/19/2024 at 07:35, 1 year 2 months ago Crossject Advances ZEPIZURE® Supply Chain Readiness Supply Chain U.S. Market ISO 13485 Crossject ZEPIZURE®
BRIEF published on 12/19/2024 at 07:35, 1 year 2 months ago Crossject améliore la préparation de la chaîne d'approvisionnement ZEPIZURE® Chaîne D'approvisionnement Marché Américain ISO 13485 Crossject ZEPIZURE®
Published on 02/21/2026 at 00:45, 1 hour 29 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 hour 44 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 3 hours 14 minutes ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 3 hours 57 minutes ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/20/2026 at 18:36, 7 hours 38 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 7 hours 43 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 8 hours 14 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 8 hours 14 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 6 hours 45 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 6 hours 45 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 8 hours 14 minutes ago TERACT - Résiliation du contrat de liquidité